Theranica Achieves Coverage for Nerivio in Over Half the U.S. Insured Population
Theranica announced that its FDA-cleared migraine treatment device, Nerivio, now has insurance coverage for over half of the insured population in the United States (158 million lives). This milestone reflects significant payer confidence and growing adoption across migraine care.
Topics: FDA-cleared devices insurance coverage expansion migraine treatment